₹357.85 on Monday.Overall revenue growth was slow during the quarter, rising 0.5%. Its consumer business managed to clock double-digit growth which helped offset the contraction in US and India formulations segment.The US market did not quite seem to benefit from the pre-covid-19 stocking, with revenues falling about 2% year-on-year.